Yungjin Pharm. Co., Ltd.
KRX:003520.KS
Overview | Financials
Company Name | Yungjin Pharm. Co., Ltd. |
Symbol | 003520.KS |
Currency | KRW |
Price | 2,330 |
Market Cap | 426,140,044,590 |
Dividend Yield | 0% |
52-week-range | 1,950 - 2,790 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Chae-Joon Lee |
Website | https://www.yungjin.co.kr |
An error occurred while fetching data.
About Yungjin Pharm. Co., Ltd.
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD